Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

01 Pubblicazione su rivista
Gelibter Alain, Occhipinti Mario, Pisegna Simona, Cortellini Alessio, Cortesi Enrico, Marchetti Paolo
ISSN: 1758-1966

Recently, clinical evidence has raised BMI as an emerging prognostic factor for immunotherapy, regardless of cancer types. In this article we rewirw current data about correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma